CNBC's full interview with Ridgeback Biotherapeutics' co-founders following promising Covid-19 pill data

Ridgeback Biotherapeutics' co-founders Dr. Wayne Holman and Wendy Holman join CNBC's "Squawk on the Street" to discuss the latest late-stage data from its Merck-partnered Covid-19 pill.